Plasma and Nuclear Fusion Research School, Nuclear Science and Technology Research Institute, Tehran, 14155-1339, Iran.
Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL, 60115-2862, USA.
Sci Rep. 2022 Oct 18;12(1):17404. doi: 10.1038/s41598-022-22429-0.
There are two major problems in proton therapy. (1) In comparison with the gamma-ray therapy, proton therapy has only ~ 10% greater biological effectiveness, and (2) the risk of the secondary neutrons in proton therapy is another unsolved problem. In this report, the increase of biological effectiveness in proton therapy has been evaluated with better performance than B in the presence of two proposed nanomaterials of GdF4 and Gd doped carbon with the thermal neutron reduction due to the presence of Gd isotope. The present study is based on the microanalysis calculations using GEANT4 Monte Carlo tool and GEANT4-DNA package for the strand breaks measurement. It was found that the proposed method will increase the effectiveness corresponding to the alpha particles by more than 100% and also, potentially will decrease the thermal neutrons fluence, significantly. Also, in this work, a discussion is presented on a significant contribution of the secondary alpha particles in total effectiveness in proton therapy.
质子治疗存在两个主要问题。(1)与伽马射线治疗相比,质子治疗的生物学效能仅提高了约 10%,(2)质子治疗中次级中子的风险是另一个尚未解决的问题。在本报告中,通过存在 Gd 同位素的情况下,使用两种新提出的纳米材料 GdF4 和 Gd 掺杂碳,评估了质子治疗中生物学效能的提高,其性能优于 B。本研究基于使用 GEANT4 蒙特卡罗工具和 GEANT4-DNA 包进行微分析计算,用于测量链断裂。结果发现,所提出的方法将使与阿尔法粒子对应的有效性提高超过 100%,并且还可能显著降低热中子通量。此外,在这项工作中,还讨论了次级阿尔法粒子在质子治疗总有效性中的重要贡献。